Eli Lilly’s second quarter eases Zepound pricing fears and suggests it’s gaining ground in weight loss race
 
"Investors were nervous going in and this print would come as a huge relief," said Mohit Bansal, an analyst at Wells Fargo.
Source link 

 
			 
							 
							